Results 211 to 220 of about 86,737 (312)

New Perspective: Bench to Bedside Evidence of the Role of CD8+ T Cells in Alzheimer's Disease. [PDF]

Immun Inflamm Dis
Peng Y, Yao SY, Wu SL, Yang H, Zhang X, Kazuo S, Liu J, Du MQ, Lin LX, Kang XH, Jiang DY.   +10 more
europepmc   +1 more source

IMMUNOCYTOCHEMICAL STUDY OF AMYLOID β PROTEIN PRECURSOR IN MOUSE AND RAT BRAINS

The KITAKANTO Medical Journal, 1993
openaire   +1 more source

Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION We investigated how plasma biomarkers (phosphorylated tau 217 [ptau217], glial fibrillary acidic protein [GFAP], neurofilament light chain [NfL]) relate to imaging markers of small vessel disease (SVD) and Alzheimer's disease (AD), and cognition in memory clinic patients.
Anna Dewenter, Katharina Bürger, Daniel Janowitz, Melina Paulus, Brigitte Nuscher, Fabian Hirsch, Benno Gesierich, Anna Steward, Lukas Frontzkowski, Sebastian N. Roemer‐Cassiano, Zeyu Zhu, Davina Biel, Madleen Klonowski, Gloria Biechele, Sophia Stoecklein, Michael Ewers, Marco Duering, Steffen Tiedt, Matthias Brendel, Nicolai Franzmeier, for the Alzheimer's Disease Neuroimaging Initiative (ADNI)   +20 more
wiley   +1 more source

Tau and β-Amyloid Relevant Pathology as a Central Therapeutic Target in Alzheimer's Disease. [PDF]

Biomolecules
Strużyńska L, Adamiak K, Sidoryk-Węgrzynowicz M.   +2 more
europepmc   +1 more source

Experimental and translational models of Alzheimer's disease: From neurodegeneration to novel therapeutic insights. [PDF]

J Prev Alzheimers Dis
Khan N, De S, Boddu S, Pravala N.
europepmc   +1 more source

Intraindividual cognitive variability predicts amyloid beta, tau PET, and dementia conversion in Down syndrome: a potential marker of cognitive resilience

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Adults with Down syndrome (DS) are at risk for Alzheimer's disease (AD), yet identifying the preclinical phase remains challenging. Intraindividual cognitive variability (IICV) may be a sensitive marker of early AD‐related changes but remains understudied in DS.
Luciana Mascarenhas Fonseca, Eardi Lila, Ali Shojaie, Jasmeer Chhatwal, Orestes Forlenza, Michal Schnaider Beeri, Sharon Krinsky‐McHale, Ann D. Cohen, Bradley T. Christian, Elizabeth Head, Mark Mapstone, Benjamin Handen, Beau M. Ances, Thomas Grabowski, Naomi S. Chaytor, Shahid Zaman, for the Alzheimer's Biomarkers Consortium‐ Down Syndrome (ABC‐DS) Investigators   +16 more
wiley   +1 more source

Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging. [PDF]

Alzheimers Dement
Hu M, Knopman DS, Therneau T, Fought AJ, Hofrenning E, Lowe VJ, Petersen RC, Algeciras-Schimnich A, Jack CR, Stricker NH, Mielke MM, Vemuri P, Graff-Radford J.   +12 more
europepmc   +1 more source

Stress, stress systems, and Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract Stress is increasingly recognized as an important, modifiable factor for Alzheimer's disease (AD), yet its roles in initiation, progression, and outcomes remain incompletely elucidated. Epidemiologic studies link chronic stress, early‐life adversity, and trauma to increased AD risk, while experimental models have uncovered mechanisms by which ...
Stephanie G. Eberly, Chayarndorn Phumsatitpong, Catherine E. Munro, Thomas C. Neylan, Daniela Kaufer, Alexander J. Ehrenberg   +5 more
wiley   +1 more source

Diet-Induced Amyloid Precursor Protein Dysregulation in Kidney and Adipose Tissue Mediates Mitochondrial Dysfunction. [PDF]

Cells
Delport A, Ally E, Maharaj S, Hewer R.
europepmc   +1 more source